×

Pharmaceutical Compositions Comprising Multi-Component Crystalline Particles Suitable for Use in Inhalation Therapy

  • US 20150366804A1
  • Filed: 01/29/2014
  • Published: 12/24/2015
  • Est. Priority Date: 01/31/2013
  • Status: Active Grant
First Claim
Patent Images

1. A composition for inhalation therapy comprising multi-component crystalline particles and also particles of fluticasone propionate, wherein the multi-component crystalline particles comprise glycopyrronium bromide and salmeterol xinafoate (GB-SX) as active ingredients and are substantially free of excipients and agents other than the active ingredients.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×